Background: Cost-coping behaviors, including skipping doses or borrowing money, are a recognized consequence of rising medication costs. Patients with diabetes mellitus (DM) have higher annual healthcare costs; however, there is limited data comparing cost-coping decisions in patients with and without DM.

Methods: We recruited 270 adults aged 35-80 with at least one chronic health condition, one medication and concern about cost. Participants were enrolled from academic multispecialty and community primary care clinics and newspaper ads. Individual hour-long surveys covered demographics, healthcare utilization and literacy, insurance, medications and diagnoses, financial strain, and provider communication. We compared survey data from patients with (n=81) and without (n=189) DM.

Results: The sample was 59% female and 83% African American. The majority had a high school education or less and 47% made less than $800 monthly. In patients with DM, monthly self-reported medication cost was higher ($92 vs. $42, p=0.001) and more variable month to month (25% vs. 15%, p=0.05). Those with DM were less likely to have never skipped doses to cut cost (44% vs. 59%, p=0.02) and were more likely to ask for and receive free samples (52% vs. 29%, p=0.0004). They were more likely to have filed for bankruptcy (38% vs. 22%, p=0.005) and reported spending less on basic needs to pay for medications (58% vs. 42%, p=0.01). These patients spent less on food/groceries first, followed by utilities, transport, and housing. More patients with DM had ever talked with a doctor about affordability of healthcare or medications (67% vs. 49%, p=0.008) and 86% were comfortable with the discussion.

Conclusion: Patients with DM are vulnerable to rising healthcare cost and utilize cost-coping strategies that could negatively affect health; however, most report being comfortable talking to a doctor about cost. Interventions that acknowledge and address cost-coping must be incorporated in practice to improve medication adherence.

Disclosure

L. Hollar: None. S. Humble: None. C.J. Herrick: Stock/Shareholder; Spouse/Partner; Cardinal Health. A.S. James: None.

Funding

National Institutes of Health (R01MD010445 to A.S.J.)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.